	LC-QQQ serum metabolomics reveals disease-specific metabolic signatures and diagnostic metabolite panels distinguishing polycythaemia vera from secondary polycythaemia. Metabolomics Halicki P, Mojsak P, Pienkowski T, Godlewski A, Kiejza D, Chmielewska S, Kretowki A, Ciborowski M, Piszcz J. PMID: 42397475 [PubMed - indexed for MEDLINE]
	Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study. Front Immunol Wan X, Liu D, Wang H, Guo W, Wang X, Zhao Y, Bai O. PMID: 42396447 [PubMed - indexed for MEDLINE]
	NeurALLNet: An attention-based spiking neural network for energy-efficient multi-class classification of acute lymphoblastic leukemia. Digit Health Hassan MR, Shanto RI, Hasan U, Momen S. PMID: 42395324 [PubMed]
	Outcome of Autologous Stem Cell Transplant in Relapsed/Refractory Hodgkin Lymphoma - A Single Center Study. J Cancer Allied Spec Ali NN, Ali N, Shaikh MU, Noor M, Moosajee M, Adil SN. PMID: 42394992 [PubMed]
	Low-dose dasatinib in second-line therapy or beyond for the treatment of chronic-phase chronic myeloid leukemia: a real-world cohort study. Front Pharmacol Chen Y, Wang H, Cheng F, Li W. PMID: 42394986 [PubMed]
	MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell Transplant. EJHaem Meng D, Alshuft H, Fox CP, Thust S, Martinez-Calle N. PMID: 42394762 [PubMed]
	Immunophenotypic Profiling of Lymphocyte Subsets in Children and Adolescents With Acute Lymphoblastic Leukaemia: Immune Dysregulation Before and After Remission. J Immunol Res Nafady-Hego H, Flemban A, Kabrah S, Abd Elmoneim HM, Aly E, Elgendy M, Albukhari T, Elgendy H, Alaa H, Almaghrabi R, Ekram SN, Nafady A. PMID: 42394164 [PubMed - indexed for MEDLINE]
	CD7 CAR-T Cell as Bridging Therapy for Successful Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory T Lymphoblastic Leukemia/ Lymphoma: A Case Report and Literature Review. Am J Case Rep Yao J, Zhang H, Zhang Y, Zhou H, Zhao Y, Zhu H, Meng J, Xiao M, Li S. PMID: 42394163 [PubMed - indexed for MEDLINE]
	A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors. Recent Pat Anticancer Drug Discov Yin M, Li X, Ye Z, Deng J, Zhang M, Li Z, Dong L, Pei S, Min A, Zhang H, Zeng L, Yang N, Zhang Y, Wang N, Jiang W, Su J, Zhou Q, Chen X. PMID: 42393893 [PubMed - as supplied by publisher]
	Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA. Am J Hematol Hoff FW, Zeidner JF, Torlapati G, Nicolet D, Mrózek K, Huang Y, Li A, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike O, Olin RL, Smith CC, Schiller GJ, Curran EK, Chan O, McMahon C, Hochman M, Sahasrabudhe K, Foucar C, Gonzalez-Lugo J, Knick Ragon B, Handa SV, Heerema NA, Chen T, Martycz M, Stefanos M, Marcus SG, Rosenberg L, Druker BJ, Levine RL, Burd A, Yocum AO, Borate UM, Mims AS, Eisfeld AK, Byrd JC, Madanat YF. PMID: 42393840 [PubMed - as supplied by publisher]
	Immunological decoding of adult T cell leukemia - its cell of origin and oncogenesis. Biomark Res Hori T. PMID: 42393792 [PubMed - as supplied by publisher]
	Azacitidine and decitabine show distinct response patterns in pediatric Myelodysplastic Syndromes and Juvenile Myelomonocytic Leukemia before HSCT: a systematic review and quantitative analysis. Clin Epigenetics Cianflone A, Cecere F, Coppola L, Cacace F, Mirabelli P, Tambaro FP. PMID: 42393761 [PubMed - as supplied by publisher]
	Diagnostic challenge of occult ER-positive breast carcinoma within bone marrow indolent B-cell lymphoma and response to CDK4/6 inhibitor: a case report. J Med Case Rep Drittone D, Mariniello M, Esposito L, Noccioli N, Maiorana G, La Verde G, Mazzuca F, Pisegna S. PMID: 42393755 [PubMed - as supplied by publisher]
	Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm. J Hematol Oncol Cartron G, Chaillol I, Houot R, Al Tabaa Y, Le Bras F, Ysebaert L, Choquet S, Jardin F, Bay JO, Gros FX, Morschhauser F, Rossi C, Gastinne T, Thieblemont C, Joris M, Ricard L, Regny C, La Rochelle LD, Feugier P, Marcais A, Ould-Ammar R, Tarte K, Laurent C, Sesques P. PMID: 42393723 [PubMed - as supplied by publisher]
	Diagnostic pitfalls and molecular insights in a rare RUNX1::TACC1-positive AML with t(8;21)(p11;q22). J Hematop Sun S, Wang Z, Chen L, Zhang X, Lin Y, Liu E, Tian X, Hou X, Yang S, Zheng Y. PMID: 42393397 [PubMed - indexed for MEDLINE]
	Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma. Blood Cancer J Chohan KL, Saul EE, Davis RE, Hagemeister F, Steiner R, Fayad L, Ahmed S, Rodriguez A, Iyer SP, Nair R, Vega F, Chihara D, Strati P, Jain P, Malpica Castillo L, Nze C, Furqan F, Chauhan A, Hamilton MP, Henderson J, Lionel AC, Flowers CR, Neelapu S, Green MR, Westin J. PMID: 42393056 [PubMed - in process]
	Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party. Lancet Haematol Bazarbachi A, Advani R, Ahmed S, Carlo-Stella C, Castagna L, Eichenauer DA, El-Cheikh J, Hamadani M, Martinez C, Nicholson E, Peggs KS, Perales MA, Schmitz N, Specht L, Tanase AD, Onida F, Ruggeri A, Rossi C, Aljurf M, André M, Sánchez-Ortega I, Yakoub-Agha I, Sureda A. PMID: 42392109 [PubMed - indexed for MEDLINE]
	The significance of galectin-9 and T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) in patients with chronic lymphocytic leukemia: The role of immune evasion. Hum Immunol Hussein S, Mohamed EM, Ebian HF, Waley AB, Alshamy MGM, Aboafya ZI, Elsayed BS, Alsharidah A, Atef N, Sakr MMH. PMID: 42391833 [PubMed - as supplied by publisher]
	Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Int J Clin Oncol Shirouchi Y, Mishima Y, Fukuhara S, Makita S, Izutsu K, Terui Y, Suzuki T, Kawasaki A, Miyake T, Maruyama D. PMID: 42390726 [PubMed - as supplied by publisher]
	The Endothelial Activation and Stress Index (EASIX) at diagnosis is associated with survival in primary central nervous system lymphoma. Br J Haematol Zhao H, Kong L, Wang J, Gao W, Zhu W, Zhao J, Yang P, Qi N, Li H, Shi X, Xiao L, An L, Chen W. PMID: 42389864 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168847

Page 1 of 8443



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy